Taking into account the role of ACE2 in cardiovascular and metabolic processes, its pharmacological activation might have the beneficial effects in the treatment of atherosclerosis and NAFLD. The gene discussed is ACE2; the disease is metabolic dysfunction-associated steatotic liver disease.